Amundi
ACAD icon

Amundi’s Acadia Pharmaceuticals ACAD Stock Holding History

Amundi’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$864K Buy
34,153
+7,400
+28% +$163K ﹤0.01% 1439
2026
Q1 		$596K Buy
26,753
+8,508
+47% +$203K ﹤0.01% 1480
2025
Q4 		$487K Sell
18,245
-4,210
-19% -$101K ﹤0.01% 1482
2025
Q3 		$485K Buy
22,455
+2,054
+10% +$48.6K ﹤0.01% 1339
2025
Q2 		$433K Buy
+20,401
New +$379K ﹤0.01% 1413

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Amundi's ACAD Position: Q2 2026 in Review

Amundi increased its Acadia Pharmaceuticals (ACAD) stake by 28% in Q2 2026, buying an estimated $163K and bringing the position to 34,153 shares worth $864K. The position accounts for ﹤0.01% of the portfolio, ranked #1439.

Amundi first reported a position in ACAD in Q2 2025 and has held it in 5 quarters since. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Amundi held 34,153 shares of Acadia Pharmaceuticals worth $864K as of Q2 2026.
  • Amundi bought 7,400 Acadia Pharmaceuticals shares in Q2 2026, an estimated $163K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1439 holding.
  • Amundi first reported a position in Acadia Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.